Results 161 to 170 of about 5,393,319 (311)

Modeling Low Muscle Mass Screening in Hemodialysis Patients.

Nephron, 2023
Senzaki D, Yoshioka N, Nagakawa O, Inayama E, Nakagawa T, Takayama H, Endo T, Nakajima F, Fukui M, Kijima Y, Oyama Y, Kudo R, Toyama T, Yamada Y, Tsurusaki K, Aoyama N, Matsumura T, Yamahara H, Miyasato K, Kitamura T, Ikenoue T.   +20 more
europepmc   +1 more source

A deep learning model for mass screening of COVID-19. [PDF]

Int J Imaging Syst Technol, 2021
Dhaka VS, Rani G, Oza MG, Sharma T, Misra A.   +4 more
europepmc   +1 more source

Visit to Breast test Wales, Cardiff

, 1997
Description of a visit to Visit to Breast test Wales, Cardiff by the National Breast Screening ...
National Breast Screening Programme
core  

p190A/ARHGAP35 and p190B/ARHGAP5 proteins in endometrial cancer: a novel cancer‐relevant paralog interplay

Molecular Oncology, EarlyView.
This study identifies ARHGAP5, in addition to the frequently mutated ARHGAP35, as significantly mutated in endometrial cancer. Mutations in both genes co‐occur and are associated with their correlated downregulation. Functional CRISPR studies show that both paralogs regulate similar pathways, including actin cytoskeleton organization.
Mathilde Pinault, Capucine Heraud, Mélissa Correia de Oliveira, Véronique Neaud, Valérie Valesco, Valérie Prouzet‐Mauleon, Béatrice Turcq, Jean‐William Dupuy, Anne‐Aurélie Raymond, Sabrina Croce, Frédéric Saltel, Valérie Lagrée, Violaine Moreau   +12 more
wiley   +1 more source

Mass screening is a key component to fight against SARS-CoV-2 and return to normalcy. [PDF]

Med Rev (2021), 2022
Feng Z, Zhang Y, Pan Y, Zhang D, Zhang L, Wang Q.   +5 more
europepmc   +1 more source

Extracellular matrix remodeling and immune reprogramming drive residual tumor progression of liver cancer after incomplete microwave ablation

Molecular Oncology, EarlyView.
Incomplete microwave ablation (iMWA) of liver cancer triggers a biphasic progression in residual tumors. At Day 3, the microenvironment is characterized by acute inflammatory responses and extracellular matrix (ECM) remodeling. By Day 14, a profound shift occurs toward oncogenic signal transduction and immunosuppression, marked by macrophage ...
Yu Liu, Yubei He, Nikolaus Berndt, Michael Mülleder, Kathrin Textoris‐Taube, Jing Guo, Matthias Stechele, Justus Ramtke, Shraga Nahum Goldberg, Lynn Jeanette Savic   +9 more
wiley   +1 more source

Mass Screening Strategies for Celiac Disease in Apparently Healthy Children and Adolescents: A Systematic Review. [PDF]

Medicina (Kaunas)
Mpakosi A, Cholevas V, Tsantes AG, Pastrikou A, Fragkiadaki A, Zhgabi S, Mougiou V, Iacovidou N, Sokou R.   +8 more
europepmc   +1 more source

Unique circulating miRNAome signatures captured with distinct molecular states in Lynch syndrome and sporadic colorectal cancer

Molecular Oncology, EarlyView.
Circulating microRNA profiles distinguish nonmalignant Lynch syndrome from cancer‐associated Lynch syndrome, sporadic colorectal cancer, and healthy controls. Age‐stratified analysis reveals disease‐specific regulatory states, and a six‐miRNA panel shows concordant separation in an independent colorectal tissue cohort.
Ramadhani Salum Chambuso, Md Shohel Ul Islam, Rosa M Xicola, Raj Ramesar, Xavier Llor, Sinclair Steele   +5 more
wiley   +1 more source

Mass Screening of Celiac Disease: A Crossing Point Between Secondary and Primary Prevention? [PDF]

Gastroenterology
Stahl MG, Leonard MM, Liu E, Pinto-Sanchez MI, Lack G, Catassi C.   +5 more
europepmc   +1 more source

A cost-benefit algorithm for rapid diagnosis of tuberculosis and rifampicin resistance detection during mass screening campaigns. [PDF]

BMC Infect Dis, 2022
Donkeng-Donfack VF, Tchatchueng-Mbougua JB, Abanda NN, Ongboulal SM, Djieugoue YJ, Kamdem Simo Y, Mekemnang Tchoupa M, Bekang Angui F, Kuate Kuate A, Mbassa V, Mvondo Abeng Belinga E, Eyangoh S.   +11 more
europepmc   +1 more source